翔宇药业 (832276.OC)

+ 收藏

现金流量表(翔宇药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 272,375,652.79515,422,468.96288,072,366.52496,277,043.93215,018,480.81
 收到的税费返还(元) 3,966.46-2,653.374,601,821.357,473.35
 收到其他与经营活动有关的现金(元) 33,425,790.9359,422,042.9610,522,155.0921,390,619.7455,665,180.07
 经营活动现金流入小计(元) 305,805,410.18574,844,511.92298,597,174.98522,269,485.02270,691,134.23
 购买商品、接受劳务支付的现金(元) 155,588,525.35361,959,617.54168,209,913.88247,625,023.85129,872,919.53
 支付给职工以及为职工支付的现金(元) 44,218,625.3993,653,672.1749,219,823.9871,326,550.1736,423,870.29
 支付的各项税费(元) 27,511,275.3267,812,037.6742,874,221.2740,679,605.2815,634,073.02
 支付其他与经营活动有关的现金(元) 35,045,719.70137,886,676.7256,832,747.2771,177,988.7846,290,867.55
 经营活动现金流出小计(元) 262,364,145.76661,312,004.10317,136,706.40430,809,168.08228,221,730.39
 经营活动产生的现金流量净额(元) 43,441,264.42-86,467,492.18-18,539,531.4291,460,316.9442,469,403.84
二、投资活动产生的现金流量
 收回投资收到的现金(元) 100.02--9,975,058.489,975,058.48
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 120,000.0035,147.2421,467.24497,448.11580,000.00
 投资活动现金流入小计(元) 120,100.0235,147.2421,467.2410,472,506.5910,555,058.48
 购建固定资产、无形资产和其他长期资产支付的现金(元) 12,018,946.991,154,861.987,545,937.456,430,920.293,828,952.48
 投资支付的现金(元) 100.00--9,988,000.009,988,000.00
 投资活动现金流出小计(元) 12,019,046.991,154,861.987,545,937.4516,418,920.2913,816,952.48
 投资活动产生的现金流量净额(元) -11,898,946.97-1,119,714.74-7,524,470.21-5,946,413.70-3,261,894.00
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 203,500,000.00207,800,000.00112,900,000.00192,800,000.00102,900,000.00
 收到其他与筹资活动有关的现金(元) 167,660,000.00321,477,208.00159,750,000.00395,454,500.00206,659,795.75
 筹资活动现金流入小计(元) 371,160,000.00529,277,208.00272,650,000.00588,254,500.00309,559,795.75
 偿还债务支付的现金(元) 103,000,000.00197,800,000.00152,900,000.00217,796,012.80127,896,012.80
 分配股利、利润或偿付利息支付的现金(元) 7,577,724.6110,002,421.345,127,970.6812,240,791.856,274,527.44
 支付其他与筹资活动有关的现金(元) 128,070,000.00275,438,048.00137,057,017.48397,075,375.39197,072,468.00
 筹资活动现金流出小计(元) 238,647,724.61483,240,469.34295,084,988.16627,112,180.04331,243,008.24
 筹资活动产生的现金流量净额(元) 132,512,275.3946,036,738.66-22,434,988.16-38,857,680.04-21,683,212.49
五、现金及现金等价物净增加额(元) 164,054,592.84-41,550,468.26-48,498,989.7946,656,223.2017,524,297.35
 加:期初现金及现金等价物余额(元) 51,460,480.2057,010,948.4657,010,948.4610,354,725.2610,354,724.90
 期末现金及现金等价物余额(元) 215,515,073.0415,460,480.208,511,958.6757,010,948.4627,879,022.25
补充资料:
 净利润(元) 29,764,829.6345,764,937.0825,000,616.9924,063,128.6820,551,751.55
 资产减值准备(元) -919,833.66-2,420,293.61-
 固定资产和投资性房地产折旧(元) 14,861,314.1632,009,790.9616,091,079.3834,573,030.8416,743,917.50
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 14,861,314.1632,009,790.9616,091,079.3834,573,030.8416,743,917.50
 无形资产摊销(元) 8,638,859.6616,014,145.338,135,389.3114,883,669.577,489,324.44
 处置固定资产、无形资产和其他长期资产的损失(元) --7,382.51-2,036.81-
 财务费用(元) 7,957,399.4310,098,129.386,060,514.7012,937,711.126,533,956.31
 递延所得税(元) -309,888.05-2,147,928.96-565,037.48-13,578,076.11-
  其中:递延所得税资产减少(元) -309,888.05-2,078,079.98-565,037.48-13,578,076.11-
 递延所得税负债增加(元) --69,848.98---
 存货的减少(元) -29,256,934.942,174,552.51-34,939,664.78-8,534,899.01-3,125,414.15
 经营性应收项目的减少(元) 26,694,122.52-61,275,735.62-4,169,035.03-32,414,989.55-9,982,291.12
 经营性应付项目的增加(元) 26,768,947.85-144,820,398.06-13,862,121.0224,872,486.4825,580,606.98
 其他(元) -43,976,136.09--24,291,019.90--23,519,978.63
 现金的期末余额(元) 215,515,073.0415,460,480.208,511,958.6757,010,948.4627,879,022.25
 减:现金的期初余额(元) 51,460,480.2057,010,948.4657,010,948.4610,354,725.2610,354,724.90
 现金及现金等价物的净增加额(元) 164,054,592.84-41,550,468.26-48,498,989.7946,656,223.2017,524,297.35
公告日期 2024-08-272024-04-192023-08-252023-04-262022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院